PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
19-Sep-2024 New Data for BRIUMVI® (ublituximab-xiiy) Demonstrate that 92% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 5 Years of Treatment TG THERAPEUTICS
19-Sep-2024 Biognosys Enters Reselling Agreement for Spectronaut Proteomics Software with Leading Provider of Mass Spectrometry Systems Biognosys
19-Sep-2024 Fasenra approved in the US for eosinophilic granulomatosis with polyangiitis AstraZeneca
19-Sep-2024 MHRA grants Benilexa® One Handed (52mg levonorgestrel intrauterine system [IUS]) an 8-year licence for contraception in the UK Gedeon Richter UK Ltd
19-Sep-2024 Poolbeg Pharma plc - Interim results for the six months to 30 June 2024 Poolbeg Pharma plc
19-Sep-2024 New drug target discovered for aggressive form of prostate cancer Institute of Cancer Research
18-Sep-2024 Multi-Cancer Early Detection Market Forecast 2024-2034: Emerging Trends, Key Players, and Growth Opportunities Prophecy Market Insights
17-Sep-2024 AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease AC Immune SA
17-Sep-2024 Improved breast cancer risk tools on the horizon as major study reaches 20-year halfway point The Institute of Cancer Research
17-Sep-2024 Arca BioLogistics Partners with Cen Global to Propel Bio-Science Logistics into The 21st Century Arca BioLogistics
17-Sep-2024 Galapagos receives transparency notification from EcoR1 Capital Galapagos
17-Sep-2024 MinervaX and Wacker Biotech Announce Manufacturing Collaboration for Prophylactic Vaccine Targeting Group B Streptococcus MinervaX
17-Sep-2024 Digital Cytology Report from IBMS and Hologic IBMS
17-Sep-2024 A global pharma showcase: MM Packaging readies for CPHI 2024 MM Packaging
17-Sep-2024 OrganaBio Expands Cell and Gene Therapy Donor Base to Include Patients with Lupus, Other Autoimmune Diseases OrganaBio
17-Sep-2024 ScaleReady announces a G-Rex® Grant has been awarded to Verismo Therapeutics Verismo Therapeutics
17-Sep-2024 AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease AC Immune SA
17-Sep-2024 ImmunOs Therapeutics AG Raises $11 Million and Further Strengthens Investor Base ImmunOs Therapeutics
16-Sep-2024 Refeyn establishes new mass photometry Scientific Advisory Board to maximize potential of transformative technology Refeyn Ltd
16-Sep-2024 AAVantgarde announces first patient dosed in First-In-Human Phase 1/2 LUCE-1 study, evaluating AAVB-081 (Dual-AAV) in retinitis pigmentosa related to Usher Syndrome type 1B AAVantgarde Bio